Alexion Pharmaceuticals Inc (ALXN)

157.53 +2.24  +1.44% NASDAQ Apr 15, 16:59 USD
View Full Chart
Price Chart
View All ALXN News

News

View All Events

Events

Date Type Description
05/06/2020 08:00 EDT Earnings Calls Q1 2020 Earnings Call
05/06/2020 00:00 Earnings Results Q1 2020 Earnings Results
05/13/2020 17:30 EDT Agm 2019 Annual General Meeting
07/30/2020 08:00 EDT Earnings Calls Q2 2020 Earnings Call
07/30/2020 00:00 Earnings Results Q2 2020 Earnings Results
10/29/2020 00:00 Earnings Results Q3 2020 Earnings Results
10/29/2020 08:00 EDT Earnings Calls Q3 2020 Earnings Call
02/04/2021 00:00 Earnings Results Q4 2020 Earnings Results
05/06/2021 08:00 Earnings Calls Q1 2021 Earnings Call
05/06/2021 00:00 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Next-generation Ultomiris is approved in PNH and aHUS. Strensiq and Kanuma target ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need in hematology, nephrology, metabolic diseases, neurology, cardiology, and other areas.
  • URL: https://www.alexion.com
  • Investor Relations URL: http://ir.alexionpharm.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: May. 06, 2021
  • Last Earnings Release: Feb. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
MNA IQ Merger Arbitrage ETF 6.11%
BBH VanEck Vectors Biotech ETF 4.74%
FBT First Trust NYSE Arca Biotech ETF 3.62%
MERFX Merger Investor 3.42%
HQH Tekla Healthcare Investors 3.26%
BCLPX BlackRock Event Driven Equity Inv C 3.03%
IBB iShares Nasdaq Biotechnology ETF 2.92%
MQIFX Franklin Mutual Quest Z 2.52%
LCMMX ClearBridge Large Cap Growth O 1.67%
JFNNX Janus Henderson Global Life Sciences N 1.51%
JLCYX JHancock Fundamental Large Cap Core R2 1.42%
XBI SPDR® S&P Biotech ETF 0.73%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.